These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19333919)

  • 21. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
    Xiang Y; Matsui T; Matsuo K; Shimada K; Tohma S; Nakamura H; Masuko K; Yudoh K; Nishioka K; Kato T
    Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.
    Ronda N; Gatti R; Giacosa R; Raschi E; Testoni C; Meroni PL; Buzio C; Orlandini G
    Arthritis Rheum; 2002 Jun; 46(6):1595-601. PubMed ID: 12115191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma.
    Lagonigro MS; Tamborini E; Negri T; Staurengo S; Dagrada GP; Miselli F; Gabanti E; Greco A; Casali PG; Carbone A; Pierotti MA; Pilotti S
    J Pathol; 2006 Apr; 208(5):615-23. PubMed ID: 16470538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
    Hénault J; Robitaille G; Senécal JL; Raymond Y
    Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.
    Soria A; Cario-André M; Lepreux S; Rezvani HR; Pasquet JM; Pain C; Schaeverbeke T; Mahon FX; Taïeb A
    Dermatology; 2008; 216(2):109-17. PubMed ID: 18216472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDGF-C and -D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries.
    Karvinen H; Rutanen J; Leppänen O; Lach R; Levonen AL; Eriksson U; Ylä-Herttuala S
    Eur J Clin Invest; 2009 Apr; 39(4):320-7. PubMed ID: 19292888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to high mobility group proteins in systemic sclerosis.
    Ayer LM; Sénecal JL; Martin L; Dixon GH; Fritzler MJ
    J Rheumatol; 1994 Nov; 21(11):2071-5. PubMed ID: 7869312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
    Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM
    Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to a collagen-specific molecular chaperone, heat-shock protein 47, in systemic sclerosis.
    Fujimoto M; Hamaguchi Y; Yazawa N; Komura K; Takehara K; Sato S
    Clin Exp Immunol; 2004 Dec; 138(3):534-9. PubMed ID: 15544633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous platelet-derived growth factor (PDGF) induces human astrocytoma cell line proliferation.
    Ranza E; Facoetti A; Morbini P; Benericetti E; Nano R
    Anticancer Res; 2007; 27(4B):2161-6. PubMed ID: 17695499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
    Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
    Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer.
    Gockel I; Moehler M; Frerichs K; Drescher D; Trinh TT; Duenschede F; Borschitz T; Schimanski K; Biesterfeld S; Herzer K; Galle PR; Lang H; Junginger T; Schimanski CC
    Oncol Rep; 2008 Oct; 20(4):845-50. PubMed ID: 18813825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
    Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.
    Daoussis D; Tsamandas AC; Liossis SN; Antonopoulos I; Karatza E; Yiannopoulos G; Andonopoulos AP
    Arthritis Res Ther; 2012 Jun; 14(3):R145. PubMed ID: 22697462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-6-anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis.
    Suzuki H; Takemura H; Yoshizaki K; Koishihara Y; Ohsugi Y; Okano A; Akiyama Y; Tojo T; Kishimoto T; Kashiwagi H
    J Immunol; 1994 Jan; 152(2):935-42. PubMed ID: 8283060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α.
    Feng H; Li Y; Yin Y; Zhang W; Hou Y; Zhang L; Li Z; Xie B; Gao WQ; Sarkaria JN; Raizer JJ; James CD; Parsa AT; Hu B; Cheng SY
    Neuro Oncol; 2015 Jun; 17(6):832-42. PubMed ID: 25468898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells.
    Russell MR; Jamieson WL; Dolloff NG; Fatatis A
    Oncogene; 2009 Jan; 28(3):412-21. PubMed ID: 18850002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.